Mexicaanse griep, 9 redenen om toch maar NIET te vaccineren

quote:

Op maandag 16 november 2009 17:26 schreef Bankfurt het volgende:

Deels wel, deels niet. Ze pakken gelijk al een stuk 60-plussers mee waar ze sowieso van af willen, lijkt mij.

quote:

Op maandag 16 november 2009 16:45 schreef Re het volgende:

[..]

omdat ze pas sinds 2 weken door hebben dat ze de complete electronische media zijn vergeten... de folders zijn trouwens wel verspreidt geloof ik.

Ik zeg dan ook dat de overheid niet slim bezig is geweest qua informatieverstrekking vooral op het internet, een log oubollig instituut, dat is het zeker

quote:

Op maandag 16 november 2009 19:14 schreef Bankfurt het volgende:

[..]

Er zijn ook heel veel twijffelaars. Veel mensen zweven tussen wel of niet doen.
Dat vergroot de onrust nog meer.
[..]

Kinderen jonger dan 4 hebben deze keuze helaas (nog) niet.

quote:

Op maandag 16 november 2009 19:24 schreef switchboy het volgende:

[..]

Die keus kúnnen ze ook helemaal nog niet maken. Die verantwoordelijkheid is van de ouders of voogd.

quote:

Op maandag 16 november 2009 19:37 schreef Bankfurt het volgende:

[..]

Hij/Zij zegt: Nee, want dat doet pijn, en gelijk heeft hij/zij.

quote:

Op maandag 16 november 2009 19:37 schreef Bankfurt het volgende:

[..]

Hij/Zij zegt: Nee, want dat doet pijn, en gelijk heeft hij/zij.

Trouwens ook voor vele volwassen mensen een goede reden. Veel mensen gaan alleen om deze reden nooit naar de tandarts.

quote:

Swedish woman got the "swine flu" in spite of vaccination against it.

In an article today in Expressen a Swedish woman tells her story about how she got the "swine flu". That would have been ordinary but in her case she was vaccinated against it five days earlier. In the article it is implied that she got the flu from someone else and that her vaccination did not "take effect" for another several days.

In reality it seems to be a typical case of someone who actually got the flu from the shot. This is a well known and well documented phenomena with many types of vaccinations.

She had no symptoms for several days but the cough and in the night "it felt like I had a thousand warriors in my body". She went to the emergency reception at the local hospital and was kept there for three days. They gave her anti viral drug Tamiflu.

Now she is very critical to how authorities in Sweden have handled the information about the poisonous Pandemrix "swine flu" shot.

"- After having received the shot, I lived in a state of false security", "Nowhere did I get the information that it would take ten days or two to three weeks for the vaccine to become effective"

bron

quote:

Op maandag 16 november 2009 21:06 schreef Lambiekje het volgende:

[..]

Geweldig. Zie vaccineren werkt niet.

quote:

Op maandag 16 november 2009 21:06 schreef Lambiekje het volgende:

[..]

Geweldig. Zie vaccineren werkt niet.

quote:

Op maandag 16 november 2009 21:06 schreef Lambiekje het volgende:
Geweldig. Zie vaccineren werkt niet.

quote:

Op zondag 15 november 2009 14:39 schreef Daniel1976 het volgende:
1 reden om niet te vaccineren. Ik heb de griep al.
Nog paar daagjes uitzieken en ik heb het gehad.

quote:

Op maandag 16 november 2009 21:37 schreef TeaserRay het volgende:
Dus ik snap in dat opzicht het hele Mexblaf probleem niet zo.

quote:

We praten nu over enkele honderden doden wereldwijd,

quote:

Op maandag 16 november 2009 21:25 schreef switchboy het volgende:

[..]

te makkelijk

We pakken even wat gegevens erbij:
http://www.emea.europa.eu(...)a-spc-h832pu17nl.pdf

Pak even paragraaf 5 erbij "5. FARMACOLOGISCHE EIGENSCHAPPEN"

ga naar de tabel die voor een deel op pag 8 en voor deen deel op pagina 9 staat. Hierin zie je dat na 1 shot en 21 dagen wachten je slechts bij 42% van de mensen een adequate antistof titer vast kunt stellen.
21 dagen na de tweede shot ligt dit percentage op afgerond 94%. Dit is dus gewoon een geval van pech hebben en te laat gevaccineerd zijn of te vroeg tegen het virus aangelopen hoe je het ook wil bekijken

quote:

Op maandag 16 november 2009 23:59 schreef Lambiekje het volgende:

[..]

ahhhhhhhh!!! Je gaat toch niet werkelijk waar emea aanhalen.

quote:

About EMEA - Structure
European Medicines Agency

Download a PDF copy here

The European Medicines Agency (EMEA) is a decentralised body of the European Union with
headquarters in London. Its main responsibility is the protection and promotion of public and animal
health, through the evaluation and supervision of medicines for human and veterinary use.

* The EMEA is responsible for the scientific evaluation of applications for European marketing authorisation for medicinal products (centralised procedure). Under the centralised procedure, companies submit a single marketing authorisation application to the EMEA. Once granted by the European Commission, a centralised (or ‘Community’) marketing authorisation is valid in all European Union (EU) and EEA-EFTA states (Iceland, Liechtenstein and Norway).
* All medicinal products for human and animal use derived from biotechnology and other hightechnology processes must be approved via the centralised procedure. The same applies to all human medicines intended for the treatment of HIV/AIDS, cancer, diabetes, neurodegenerative diseases, auto-immune and other immune dysfunctions, and viral diseases, as well as to all designated orphan medicines intended for the treatment of rare diseases. Similarly, all veterinary medicines intended for use as performance enhancers in order to promote the growth of treated animals or to increase yields from treated animals have to go through the centralised procedure.
* For medicinal products that do not fall under any of the above-mentioned categories, companies can submit an application for a centralised marketing authorisation to the EMEA, provided the medicinal product constitutes a significant therapeutic, scientific or technical innovation, or the product is in any other respect in the interest of patient or animal health.
* The safety of medicines is monitored constantly by the Agency through a pharmacovigilance network. The EMEA takes appropriate actions if adverse drug reaction reports suggest changes to the benefit-risk balance of a medicinal product. For veterinary medicinal products, the Agency has the responsibility to establish safe limits for medicinal residues in food of animal origin.
* The Agency also plays a role in stimulating innovation and research in the pharmaceutical sector. The EMEA gives scientific advice and protocol assistance to companies for the development of new medicinal products. It publishes guidelines on quality, safety and efficacy testing requirements. A dedicated office established in 2005 provides special assistance to small and medium-sized enterprises (SMEs).
* Six scientific committees, composed of members of all EU and EEA-EFTA states, some including patients’ and doctors’ representatives, conduct the main scientific work of the Agency: the Committee for Medicinal Products for Human Use (CHMP), the Committee for Medicinal Products for Veterinary Use (CVMP), the Committee for Orphan Medicinal Products (COMP), the Committee on Herbal Medicinal Products (HMPC), the Paediatric Committee (PDCO) and the Committee for Advanced Therapies (CAT).
* The Agency brings together the scientific resources of over 40 national competent authorities in 30 EU and EEA-EFTA countries in a network of over 4,500 European experts. It contributes to the European Union’s international activities through its work with the European Pharmacopoeia, the World Health Organization, and the ICH and VICH trilateral (EU, Japan and US) conferences on harmonisation, among other international organisations and initiatives.
* The EMEA is headed by the Executive Director and has a secretariat of approximately 530 staff members in 2008. The Management Board is the supervisory body of the EMEA, responsible, in particular, for budgetary matters.
* The Agency is also involved in referral procedures relating to medicinal products that are approved or under consideration by Member States in non-centralised authorisation procedures.